MAPT and Alzheimer disease: Using data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), we here report the abnormal tau-PET binding patterns in individuals classified as being cognitively unimpaired (CU) or having mild cognitive impairment (MCI) or Alzheimer’s disease dementia.